Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001683168-21-003220
Filing Date
2021-08-02
Accepted
2021-08-02 17:11:35
Documents
5

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT pharmacyte_424b5.htm 424B5 718142
2 GRAPHIC image_001.jpg GRAPHIC 3063
3 GRAPHIC image_002.jpg GRAPHIC 25664
4 GRAPHIC image_003.jpg GRAPHIC 23383
5 GRAPHIC image_004.jpg GRAPHIC 3070
  Complete submission text file 0001683168-21-003220.txt   795897
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 424B5 | Act: 33 | File No.: 333-255044 | Film No.: 211136918
SIC: 2836 Biological Products, (No Diagnostic Substances)